476 related articles for article (PubMed ID: 30253099)
1. Machine Learning Classification and Structure-Functional Analysis of Cancer Mutations Reveal Unique Dynamic and Network Signatures of Driver Sites in Oncogenes and Tumor Suppressor Genes.
Agajanian S; Odeyemi O; Bischoff N; Ratra S; Verkhivker GM
J Chem Inf Model; 2018 Oct; 58(10):2131-2150. PubMed ID: 30253099
[TBL] [Abstract][Full Text] [Related]
2. Biophysical simulations and structure-based modeling of residue interaction networks in the tumor suppressor proteins reveal functional role of cancer mutation hotspots in molecular communication.
Verkhivker GM
Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):210-225. PubMed ID: 30339916
[TBL] [Abstract][Full Text] [Related]
3. Integration of Random Forest Classifiers and Deep Convolutional Neural Networks for Classification and Biomolecular Modeling of Cancer Driver Mutations.
Agajanian S; Oluyemi O; Verkhivker GM
Front Mol Biosci; 2019; 6():44. PubMed ID: 31245384
[TBL] [Abstract][Full Text] [Related]
4. LOTUS: A single- and multitask machine learning algorithm for the prediction of cancer driver genes.
Collier O; Stoven V; Vert JP
PLoS Comput Biol; 2019 Sep; 15(9):e1007381. PubMed ID: 31568528
[TBL] [Abstract][Full Text] [Related]
5. DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies.
Han Y; Yang J; Qian X; Cheng WC; Liu SH; Hua X; Zhou L; Yang Y; Wu Q; Liu P; Lu Y
Nucleic Acids Res; 2019 May; 47(8):e45. PubMed ID: 30773592
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the evaluation of cancer driver genes.
Tokheim CJ; Papadopoulos N; Kinzler KW; Vogelstein B; Karchin R
Proc Natl Acad Sci U S A; 2016 Dec; 113(50):14330-14335. PubMed ID: 27911828
[TBL] [Abstract][Full Text] [Related]
7. SomInaClust: detection of cancer genes based on somatic mutation patterns of inactivation and clustering.
Van den Eynden J; Fierro AC; Verbeke LP; Marchal K
BMC Bioinformatics; 2015 Apr; 16():125. PubMed ID: 25903787
[TBL] [Abstract][Full Text] [Related]
8. Why Are Some Driver Mutations Rare?
Nussinov R; Tsai CJ; Jang H
Trends Pharmacol Sci; 2019 Dec; 40(12):919-929. PubMed ID: 31699406
[TBL] [Abstract][Full Text] [Related]
9. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.
Shi MJ; Meng XY; Fontugne J; Chen CL; Radvanyi F; Bernard-Pierrot I
Genome Med; 2020 Sep; 12(1):85. PubMed ID: 32988402
[TBL] [Abstract][Full Text] [Related]
10. Discovering potential cancer driver genes by an integrated network-based approach.
Shi K; Gao L; Wang B
Mol Biosyst; 2016 Aug; 12(9):2921-31. PubMed ID: 27426053
[TBL] [Abstract][Full Text] [Related]
11. Machine learning methods for prediction of cancer driver genes: a survey paper.
Andrades R; Recamonde-Mendoza M
Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35323900
[TBL] [Abstract][Full Text] [Related]
12. A CATH domain functional family based approach to identify putative cancer driver genes and driver mutations.
Ashford P; Pang CSM; Moya-García AA; Adeyelu T; Orengo CA
Sci Rep; 2019 Jan; 9(1):263. PubMed ID: 30670742
[TBL] [Abstract][Full Text] [Related]
13. The pan-cancer analysis of gain-of-functional mutations to identify the common oncogenic signatures in multiple cancers.
Wee Y; Liu Y; Bhyan SB; Lu J; Zhao M
Gene; 2019 May; 697():57-66. PubMed ID: 30796966
[TBL] [Abstract][Full Text] [Related]
14. Identification and analysis of mutational hotspots in oncogenes and tumour suppressors.
Baeissa H; Benstead-Hume G; Richardson CJ; Pearl FMG
Oncotarget; 2017 Mar; 8(13):21290-21304. PubMed ID: 28423505
[TBL] [Abstract][Full Text] [Related]
15. A Novel Method for Identifying the Potential Cancer Driver Genes Based on Molecular Data Integration.
Zhang W; Wang SL
Biochem Genet; 2020 Feb; 58(1):16-39. PubMed ID: 31115714
[TBL] [Abstract][Full Text] [Related]
16. In silico saturation mutagenesis of cancer genes.
Muiños F; Martínez-Jiménez F; Pich O; Gonzalez-Perez A; Lopez-Bigas N
Nature; 2021 Aug; 596(7872):428-432. PubMed ID: 34321661
[TBL] [Abstract][Full Text] [Related]
17. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
Narayan S; Bader GD; Reimand J
Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
[TBL] [Abstract][Full Text] [Related]
18. Mutational landscape of RNA-binding proteins in human cancers.
Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
[TBL] [Abstract][Full Text] [Related]
19. Multi-Omic Data Improve Prediction of Personalized Tumor Suppressors and Oncogenes.
Sudhakar M; Rengaswamy R; Raman K
Front Genet; 2022; 13():854190. PubMed ID: 35620468
[TBL] [Abstract][Full Text] [Related]
20. The Integrative Method Based on the Module-Network for Identifying Driver Genes in Cancer Subtypes.
Lu X; Li X; Liu P; Qian X; Miao Q; Peng S
Molecules; 2018 Jan; 23(2):. PubMed ID: 29364829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
